Corbus Pharmaceuticals Holdings, Inc. — SC 13G/A Filings
44 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Corbus Pharmaceuticals Holdings, Inc. (CRBP), sorted by most recent first. Each row links to the full filing on EdgarLookup. Corbus Pharmaceuticals Holdings, Inc. has filed 44 SC 13G/A documents with the SEC since 2014. To view all SEC filings by Corbus Pharmaceuticals Holdings, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
424B3
424B5
5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-3MEF
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | CORBUS PHARMACEUTICALS HOLDINGS, INC. | 0000902664-24-006642 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001140361-24-046892 | Nov 14, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0001214659-24-019105 | Nov 14, 2024 | — |
| SC 13G/A | — | 0001172661-24-005058 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000932471-24-000998 | Nov 12, 2024 | — |
| SC 13G/A | CORBUS PHARMACEUTICALS HOLDINGS, INC. | 0000902664-24-006420 | Nov 12, 2024 | — |
| SC 13G/A | — | 0000932471-24-000364 | Nov 4, 2024 | — |
| SC 13G/A | — | 0001273087-24-000100 | Oct 15, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 | 0000929638-24-001033 | Mar 18, 2024 | — |
| SC 13G/A | SC 13G/A | 0001140361-24-008026 | Feb 14, 2024 | — |
| SC 13G/A | AMENDMENT NO. 18 TO SCHEDULE 13G | 0001213900-22-050731 | Aug 24, 2022 | — |
| SC 13G/A | AMENDMENT NO. 17 TO SCHEDULE 13G | 0001213900-22-007461 | Feb 14, 2022 | — |
| SC 13G/A | AMENDMENT NO.16 TO SCHEDULE 13G | 0001213900-21-030186 | Jun 1, 2021 | — |
| SC 13G/A | AMENDMENT NO.15 TO SCHEDULE 13G | 0001213900-21-025576 | May 11, 2021 | — |
| SC 13G/A | — | 0000834237-21-008113 | Apr 12, 2021 | — |
| SC 13G/A | AMENDMENT NO. 14 TO SCHEDULE 13G | 0001213900-21-016035 | Mar 17, 2021 | — |
| SC 13G/A | AMENDMENT NO. 13 TO SCHEDULE 13G | 0001213900-21-009356 | Feb 16, 2021 | — |
| SC 13G/A | AMENDMENT NO. 12 TO SCHEDULE 13G | 0001213900-21-008829 | Feb 12, 2021 | — |
| SC 13G/A | — | 0000834237-21-002988 | Jan 29, 2021 | — |
| SC 13G/A | AMENDMENT NO. 11 TO SCHEDULE 13G | 0001213900-21-001112 | Jan 8, 2021 | — |
| SC 13G/A | AMENDMENT NO. 10 TO SCHEDULE 13G | 0001213900-20-042180 | Dec 11, 2020 | — |
| SC 13G/A | AMENDMENT NO. 9 TO SCHEDULE 13G | 0001213900-20-037197 | Nov 16, 2020 | — |
| SC 13G/A | AMENDMENT NO. 8 TO SCHEDULE 13G | 0001213900-20-035462 | Nov 6, 2020 | — |
| SC 13G/A | AMENDMENT NO. 7 TO SCHEDULE 13G | 0001213900-20-020809 | Aug 7, 2020 | — |
| SC 13G/A | AMENDMENT NO. 6 TO SCHEDULE 13G | 0001213900-20-010018 | Apr 24, 2020 | — |
| SC 13G/A | AMENDMENT NO. 5 TO SCHEDULE 13G | 0001213900-20-006823 | Mar 19, 2020 | — |
| SC 13G/A | SC 13G/A | 0001104659-20-021777 | Feb 14, 2020 | — |
| SC 13G/A | — | 0000834237-20-005448 | Feb 5, 2020 | — |
| SC 13G/A | AMENDMENT NO. 4 TO SCHEDULE 13G | 0001213900-19-025087 | Dec 2, 2019 | — |
| SC 13G/A | SC 13G/A | 0001615774-19-009075 | Jun 3, 2019 | — |
| SC 13G/A | SC 13G/A | 0001615774-19-006505 | Apr 29, 2019 | — |
| SC 13G/A | SC 13G/A | 0001615774-19-002673 | Feb 19, 2019 | — |
| SC 13G/A | SC 13G/A | 0000905718-19-000212 | Feb 14, 2019 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001144204-19-007532 | Feb 14, 2019 | — |
| SC 13G/A | — | 0000215457-19-003233 | Feb 4, 2019 | — |
| SC 13G/A | — | 0000929638-18-000288 | Feb 14, 2018 | — |
| SC 13G/A | SC 13G/A | 0001144204-18-008860 | Feb 14, 2018 | — |
| SC 13G/A | CORBUS PHARMACEUTICALS 13G AMENDMENT NO. 2 | 0000905718-18-000208 | Feb 14, 2018 | — |
| SC 13G/A | SC 13G/A | 0001144204-17-012935 | Mar 6, 2017 | — |
| SC 13G/A | SC 13G/A | 0001615774-17-000868 | Mar 2, 2017 | — |
| SC 13G/A | SC 13G/A | 0001144204-17-008928 | Feb 14, 2017 | — |
| SC 13G/A | — | 0000929638-17-000221 | Feb 14, 2017 | — |
| SC 13G/A | SC 13G/A | 0000905718-17-000238 | Feb 14, 2017 | — |
| SC 13G/A | SC 13G/A | 0000905718-17-000242 | Feb 14, 2017 | — |